Association Between Corticosteroids and Infection, Sepsis, and Infectious Death in Pediatric Acute Myeloid Leukemia (AML): Results From the Canadian Infections in AML Research Group
Open Access
- 5 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (12), 1608-1614
- https://doi.org/10.1093/cid/cis774
Abstract
Background. Infection continues to be a major problem for children with acute myeloid leukemia (AML). Objectives were to identify factors associated with infection, sepsis, and infectious deaths in children with newly diagnosed AML. Methods. We conducted a retrospective, population-based cohort study that included children ≤18 years of age with de novo, non-M3 AML diagnosed between January 1995 and December 2004, treated at 15 Canadian centers. Patients were monitored for infection from initiation of AML treatment until recovery from the last cycle of chemotherapy, conditioning for hematopoietic stem cell transplantation, relapse, persistent disease, or death (whichever occurred first). Consistent trained research associates abstracted all information from each site. Results. 341 patients were included. Median age was 7.1 years (interquartile range [IQR], 2.0–13.5) and 29 (8.5%) had Down syndrome. In sum, 26 (7.6%) experienced death as a first event. There were 1277 courses of chemotherapy administered in which sterile site microbiologically documented infection occurred in 313 courses (24.5%). Sepsis and infectious death occurred in 97 (7.6%) and 16 (1.3%) courses, respectively. The median days of corticosteroid administration was 2 per course (IQR, 0–6). In multiple regression analysis, duration of corticosteroid exposure was significantly associated with more microbiologically documented sterile site infection, bacteremia, fungal infection, and sepsis. The only factor significantly associated with infectious death was days of corticosteroid exposure (odds ratio, 1.05; 95% confidence interval, 1.02–1.08; P = .001). Conclusions. In pediatric AML, infection, sepsis, and infectious death were associated with duration of corticosteroid exposure. Corticosteroids should be avoided when possible for this population.Keywords
This publication has 26 references indexed in Scilit:
- Life-threatening and Fatal Infections in Children With Acute Myeloid LeukemiaJournal of Pediatric Hematology/Oncology, 2012
- Early and treatment‐related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984–2003British Journal of Haematology, 2010
- Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: Results from a multi-center Italian studyPediatric Blood & Cancer, 2010
- Infections and association with different intensity of chemotherapy in children with acute myeloid leukemiaCancer, 2009
- Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemiaBlood, 2007
- Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93Leukemia, 2003
- Prospective, Multicenter Evaluation of Risk Factors Associated With Invasive Bacterial Infection in Children With Cancer, Neutropenia, and FeverJournal of Clinical Oncology, 2001
- Alpha Hemolytic Streptococcal Infection During Intensive Treatment for Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study CCG-2891Journal of Clinical Oncology, 2000
- A Prospective Search for Ocular Lesions in Hospitalized Patients with Significant BacteremiaClinical Infectious Diseases, 2000
- A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studiesBritish Journal of Haematology, 1997